Cost-benefit thresholds are outdated, says MPs' report

The health select committee has recommended sweeping changes to the way the National Institute for Health and Clinical Excellence assesses what drugs and treatments should be available on the NHS.

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here